The effect of low-dose phenobarbitone on three indices of hepatic microsomal enzyme induction.
Open Access
- 1 December 1986
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 22 (6) , 744-747
- https://doi.org/10.1111/j.1365-2125.1986.tb02970.x
Abstract
The effects of low-dose phenobarbitone on three indices of hepatic enzyme induction were studied. Eight healthy volunteers took phenobarbitone 7.5 mg daily for 4 weeks followed by 15 mg daily for 4 weeks; five subjects took 30 mg daily for a further 2 weeks. Phenobarbitone 15 mg daily produced a significant rise in antipyrine clearance (P less than 0.05). Phenobarbitone 30 mg daily produced a further rise, but probably because of the reduced numbers of subjects, this did not achieve significance (P = 0.06). Urinary 6-beta- hydroxycortisol and D-glucaric acid levels did not change significantly and remained within the range seen in subjects not taking enzyme- inducing drugs. We conclude that phenobarbitone 7.5 mg daily produces little (if any) enzyme induction whereas 15 mg, or more, may have the potential to produce drug interactions through enzyme induction.This publication has 13 references indexed in Scilit:
- Use of Low-Dose Phenobarbitone to Assess Patient ComplianceClinical Science, 1984
- Phenobarbital in the Monitoring of ComplianceAnnals of Internal Medicine, 1984
- Effect of low-dose phenobarbital on hepatic microsomal udp-glucuronyl transferase activityBiochemical Pharmacology, 1983
- Analysis of barbiturates in blood by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- Effect of low‐dose phenobarbitone on five indirect indices of hepatic microsomal enzyme induction and plasma lipoproteins in normal subjects [letter]British Journal of Clinical Pharmacology, 1981
- Measurement of urinary 6-?-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicinEuropean Journal of Clinical Pharmacology, 1979
- Assay of Antipyrine and Its Primary Metabolites in Plasma, Saliva and Urine by High-Performance Liquid Chromatography and Some Preliminary Results in ManPharmacology, 1979
- A direct radioimmunoassay for 6β-hydroxycortisol in human urineThe Journal of Steroid Biochemistry and Molecular Biology, 1978
- Clinical Implications of Enzyme InductionPublished by Springer Nature ,1975
- Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in manJournal of Clinical Investigation, 1969